Over $80M BARDA Prize to Create New H5N1 Vaccines to Prepare for “Future” Bird Flu Pandemic
The Biomedical Advanced Research and Development Authority (BARDA) has launched an $80+ million multi-stage competition for “vaccine developers and researchers, biotech companies, and other innovators” to develop vaccines for pandemic influenza A, or A(H5) bird flu, which includes highly pathogenic avian influenza A(H5N1). The name of the competition is Single Shield Prize, and it “calls […]
BARDA Awards $9.27 Million Contract to Evaluate Oral Pill COVID Vaccine
Biotechnology firm Vaxart, Inc. announced on Jan. 19, 2024 that it received a $9.27 million contract from the U.S. Biomedical Advanced Research and Development Authority (BARDA) to fund preparations for a Phase IIb clinical trial to evaluate the company’s oral pill XXB COVID-19 vaccine candidate. The trial is expected to involve 10,000 participants and will […]